Filana Therapeutics, Inc. (FLNA) vs Werewolf Therapeutics, Inc. (HOWL)
A side-by-side comparison of Filana Therapeutics, Inc. and Werewolf Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FLNA
Filana Therapeutics, Inc.
$0.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HOWL
Werewolf Therapeutics, Inc.
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FLNA vs HOWL
growth of $100 · dividends reinvested · last 1yFLNA -57.6% (-57.6%/yr)HOWL +41.1% (+41.1%/yr)HOWL compounded faster over this window
FLNA HOWL
FLNA vs HOWL: by the numbers
- •HOWL is the larger company ($45M vs $42M market cap).
- •Both run net losses; FLNA's is the smaller (0.00% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | FLNA | HOWL |
|---|---|---|
| P/S ratio | N/A | 2.13 |
| P/B ratio | 0.66 | 2.74 |
Profitability
| Metric | FLNA | HOWL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -164.82% |
| ROE | -66.47% | -212.45% |
| ROIC | -72.12% | -156.97% |
Growth (annualized)
| Metric | FLNA | HOWL |
|---|---|---|
| Total return CAGR (5Y) | N/A | -44.27% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.